{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,8]],"date-time":"2025-12-08T22:00:08Z","timestamp":1765231208685,"version":"3.37.3"},"reference-count":75,"publisher":"Bentham Science Publishers Ltd.","issue":"5","funder":[{"DOI":"10.13039\/501100011915","name":"Taylor's Internal Research Grant Scheme","doi-asserted-by":"publisher","award":["TRGS\/ERFS\/1\/2018\/SBS\/034"],"award-info":[{"award-number":["TRGS\/ERFS\/1\/2018\/SBS\/034"]}],"id":[{"id":"10.13039\/501100011915","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["ACAMC"],"published-print":{"date-parts":[[2022,3]]},"abstract":"<jats:sec>\n<jats:title>Background:<\/jats:title>\n<jats:p>The lack of specificity, severe side effects, and development of drug resistance have largely\nlimited the use of platinum-based compounds in cancer treatment. Therefore, copper complexes have emerged as potential\nalternatives to platinum-based compounds.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Objective:<\/jats:title>\n<jats:p>Ternary copper (II) complex incorporated with 1-10-phenanthroline and L-tyrosine was investigated for its\nanti-cancer effects in HT-29 colorectal cancer cells.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Methods:<\/jats:title>\n<jats:p>Cytotoxic effects of ternary copper (II) complex in HT-29 cells was evaluated using MTT assay, Real-Time\nCell Analysis (RTCA) and lactate dehydrogenase (LDH) assay. Cell cycle analysis was performed using flow cytometry.\nApoptosis induction was studied by Annexin V-FITC\/Propidium Iodide (PI) staining and mitochondrial membrane\npotential analysis (JC-10 staining) using flow cytometry. Intracellular Reactive Oxygen Species (ROS) were detected\nby DCFH-DA assay. The expression of proteins involved in the apoptotic signalling pathway (p53, caspases, and\nPARP-1) was evaluated by western blot analysis.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Results:<\/jats:title>\n<jats:p>Ternary copper (II) complex reduced the cell viability of HT-29 cells in a time- and dose-dependent manner,\nwith IC50 of 2.4 \u00b1 0.4 and 0.8 \u00b1 0.04 \u03bcM at 24 and 48 hours, respectively. Cell cycle analysis demonstrated induction of\nS-phase cell cycle arrest. Morphological evaluation and Annexin V-FITC\/PI flow cytometry analysis confirmed induction\nof apoptosis that was further supported by cleavage and activation of caspase-8, caspase-9, caspase-3, and PARP-\n1. Mutant p53 was also downregulated in a dose-dependent manner. No LDH release, mitochondrial membrane potential\ndisruption, and ROS production were observed.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Conclusion:<\/jats:title>\n<jats:p>Ternary copper (II) complex holds great potential to be developed for colorectal cancer treatment.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/1871520621666210708100019","type":"journal-article","created":{"date-parts":[[2021,7,9]],"date-time":"2021-07-09T03:53:06Z","timestamp":1625802786000},"page":"999-1011","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Ternary Copper (II) Complex Induced Apoptosis and Cell Cycle Arrest in Colorectal\nCancer Cells"],"prefix":"10.2174","volume":"22","author":[{"given":"Sathiavani","family":"Arikrishnan","sequence":"first","affiliation":[{"name":"School of Biosciences, Faculty of Health and Medical Sciences, Taylor\\'s University, 1, Jalan Taylors, 47500, Subang Jaya, Selangor,\nMalaysia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jian Sheng","family":"Loh","sequence":"first","affiliation":[{"name":"School of Pharmacy, Faculty of Health and Medical Sciences, Taylor\\'s University, 1, Jalan Taylors, 47500, Subang Jaya,\nSelangor, Malaysia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4354-1486","authenticated-orcid":true,"given":"Yin Sim","family":"Tor","sequence":"first","affiliation":[{"name":"School of Biosciences, Faculty of Health and Medical Sciences, Taylor\\'s University, 1, Jalan Taylors, 47500, Subang Jaya, Selangor, Malaysia"},{"name":"Centre for Drug Discovery and Molecular Pharmacology (CDDMP),\nFaculty of Health &amp; Medical Sciences, Taylor\u2019s University, 1, Jalan Taylors, 47500, Subang Jaya, Selangor, Malaysia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xian Wei","family":"Teo","sequence":"additional","affiliation":[{"name":"School of Pharmacy, Faculty of Health and Medical Sciences, Taylor\\'s University, 1, Jalan Taylors, 47500, Subang Jaya,\nSelangor, Malaysia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Faris","family":"bin Norizan","sequence":"additional","affiliation":[{"name":"School of Pharmacy, Faculty of Health and Medical Sciences, Taylor\\'s University, 1, Jalan Taylors, 47500, Subang Jaya,\nSelangor, Malaysia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"May Lee","family":"Low","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Chemistry, School of Pharmacy, International Medical University, 126, Jalan\nJalil Perkasa 19, Bukit Jalil, 57000, Kuala Lumpur, Malaysia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sau Har","family":"Lee","sequence":"additional","affiliation":[{"name":"School of Biosciences, Faculty of Health and Medical Sciences, Taylor\\'s University, 1, Jalan Taylors, 47500, Subang Jaya, Selangor,\nMalaysia"},{"name":"Centre for Drug Discovery and Molecular Pharmacology (CDDMP),\nFaculty of Health &amp; Medical Sciences, Taylor\u2019s University, 1, Jalan Taylors, 47500, Subang Jaya, Selangor, Malaysia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jhi Biau","family":"Foo","sequence":"additional","affiliation":[{"name":"School of Pharmacy, Faculty of Health and Medical Sciences, Taylor\\'s University, 1, Jalan Taylors, 47500, Subang Jaya,\nSelangor, Malaysia"},{"name":"Centre for Drug Discovery and Molecular Pharmacology (CDDMP),\nFaculty of Health &amp; Medical Sciences, Taylor\u2019s University, 1, Jalan Taylors, 47500, Subang Jaya, Selangor, Malaysia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1016\/S0140-6736(19)32319-0","volume":"394","author":"Dekker E.","year":"2019","unstructured":"Dekker E.; Tanis P.J.; Vleugels J.L.A.; Kasi P.M.; Wallace M.B.; Colorectal cancer. Lancet 2019,394(10207),1467-1480","journal-title":"Lancet"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"15065","DOI":"10.1038\/nrdp.2015.65","volume":"1","author":"Kuipers E.J.","year":"2015","unstructured":"Kuipers E.J.; Grady W.M.; Lieberman D.; Seufferlein T.; Sung J.J.; Boelens P.G.; van de Velde C.J.H.; Watanabe T.; Colorectal cancer. Nat Rev Dis Primers 2015,1,15065","journal-title":"Nat Rev Dis Primers"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3322\/caac.21492","volume":"68","author":"Bray F.","year":"2018","unstructured":"Bray F.; Ferlay J.; Soerjomataram I.; Siegel R.L.; Torre L.A.; Jemal A.; Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2018,68(6),394-424","journal-title":"CA Cancer J Clin"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.1007\/s00432-018-2669-6","volume":"144","author":"Armstrong-Gordon E.","year":"2018","unstructured":"Armstrong-Gordon E.; Gnjidic D.; McLachlan A.J.; Hosseini B.; Grant A.; Beale P.J.; Wheate N.J.; Patterns of platinum drug use in an acute care setting: A retrospective study. J Cancer Res Clin Oncol 2018,144(8),1561-1568","journal-title":"J Cancer Res Clin Oncol"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"1609","DOI":"10.1056\/NEJMoa1403108","volume":"371","author":"Loupakis F.","year":"2014","unstructured":"Loupakis F.; Cremolini C.; Masi G.; Lonardi S.; Zagonel V.; Salvatore L.; Cortesi E.; Tomasello G.; Ronzoni M.; Spadi R.; Zaniboni A.; Tonini G.; Buonadonna A.; Amoroso D.; Chiara S.; Carlomagno C.; Boni C.; Allegrini G.; Boni L.; Falcone A.; Initial therapy with folfoxiri and bevacizumab for metastatic colorectal cancer. N Engl J Med 2014,371(17),1609-1618","journal-title":"N Engl J Med"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"1306","DOI":"10.1016\/S1470-2045(15)00122-9","volume":"16","author":"Cremolini C.","year":"2015","unstructured":"Cremolini C.; Loupakis F.; Antoniotti C.; Lupi C.; Sensi E.; Lonardi S.; Mezi S.; Tomasello G.; Ronzoni M.; Zaniboni A.; Tonini G.; Carlomagno C.; Allegrini G.; Chiara S.; D\u2019Amico M.; Granetto C.; Cazzaniga M.; Boni L.; Fontanini G.; Falcone A.; FOLFOXIRI plus bevacizumab versus FOLFIRI plus bevacizumab as first-line treatment of patients with metastatic colorectal cancer: Updated overall survival and molecular subgroup analyses of the open-label, phase 3 TRIBE study. Lancet Oncol 2015,16(13),1306-1315","journal-title":"Lancet Oncol"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"e170278","DOI":"10.1001\/jamaoncol.2017.0278","volume":"3","author":"Tomasello G.","year":"2017","unstructured":"Tomasello G.; Petrelli F.; Ghidini M.; Russo A.; Passalacqua R.; Barni S.; FOLFOXIRI plus bevacizumab as conversion therapy for patients with initially unresectable metastatic colorectal cancer: A systematic review and pooled analysis. JAMA Oncol 2017,3(7),e170278-e170278","journal-title":"JAMA Oncol"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/j.jinorgbio.2016.04.004","volume":"160","author":"S\u00f8rensen B.H.","year":"2016","unstructured":"S\u00f8rensen B.H.; Dam C.S.; St\u00fcrup S.; Lambert I.H.; Dual role of LRRC8A-containing transporters on cisplatin resistance in human ovarian cancer cells. J Inorg Biochem 2016,160,287-295","journal-title":"J Inorg Biochem"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"2993","DOI":"10.15252\/embj.201592409","volume":"34","author":"Planells-Cases R.","year":"2015","unstructured":"Planells-Cases R.; Lutter D.; Guyader C.; Gerhards N.M.; Ullrich F.; Elger D.A.; Kucukosmanoglu A.; Xu G.; Voss F.K.; Reincke S.M.; Stauber T.; Blomen V.A.; Vis D.J.; Wessels L.F.; Brummelkamp T.R.; Borst P.; Rottenberg S.; Jentsch T.J.; Subunit composition of VRAC channels determines substrate specificity and cellular resistance to Pt-based anti-cancer drugs. EMBO J 2015,34(24),2993-3008","journal-title":"EMBO J"},{"key":"ref=10","doi-asserted-by":"publisher","DOI":"10.1038\/s41568-020-00308-y","volume":"2020","author":"Rottenberg S.","year":"2020","unstructured":"Rottenberg S.; Disler C.; Perego P.;  The rediscovery of platinum-based cancer therapy  Nat Rev Cancer 2020,2020","journal-title":"The rediscovery of platinum-based cancer therapy  Nat Rev Cancer"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1038\/nchembio.2098","volume":"12","author":"Krishnamoorthy L.","year":"2016","unstructured":"Krishnamoorthy L.; Cotruvo J.A.; Chan J.; Kaluarachchi H.; Muchenditsi A.; Pendyala V.S.; Jia S.; Aron A.T.; Ackerman C.M.; Wal M.N.V.; Guan T.; Smaga L.P.; Farhi S.L.; New E.J.; Lutsenko S.; Chang C.J.; Copper regulates cyclic-AMP-dependent lipolysis. Nat Chem Biol 2016,12(8),586-592","journal-title":"Nat Chem Biol"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"19507","DOI":"10.1073\/pnas.1318431110","volume":"110","author":"Ishida S.","year":"2013","unstructured":"Ishida S.; Andreux P.; Poitry-Yamate C.; Auwerx J.; Hanahan D.; Bioavailable copper modulates oxidative phosphorylation and growth of tumors. Proc Natl Acad Sci USA 2013,110(48),19507-19512","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1038\/s41556-020-0481-4","volume":"22","author":"Tsang T.","year":"2020","unstructured":"Tsang T.; Posimo J.M.; Gudiel A.A.; Cicchini M.; Feldser D.M.; Brady D.C.; Copper is an essential regulator of the autophagic kinases ULK1\/2 to drive lung adenocarcinoma. Nat Cell Biol 2020,22(4),412-424","journal-title":"Nat Cell Biol"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"185","DOI":"10.2174\/187152009787313837","volume":"9","author":"Marzano C.","year":"2009","unstructured":"Marzano C.; Pellei M.; Tisato F.; Santini C.; Copper complexes as anticancer agents. Anticancer Agents Med Chem 2009,9(2),185-211","journal-title":"Anticancer Agents Med Chem"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1038\/nature13180","volume":"509","author":"Brady D.C.","year":"2014","unstructured":"Brady D.C.; Crowe M.S.; Turski M.L.; Hobbs G.A.; Yao X.; Chaikuad A.; Knapp S.; Xiao K.; Campbell S.L.; Thiele D.J.; Counter C.M.; Copper is required for oncogenic BRAF signalling and tumorigenesis. Nature 2014,509(7501),492-496","journal-title":"Nature"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"6240","DOI":"10.1158\/0008-5472.CAN-16-1190","volume":"77","author":"Brady D.C.","year":"2017","unstructured":"Brady D.C.; Crowe M.S.; Greenberg D.N.; Counter C.M.; Copper chelation inhibits brafv600e-driven melanomagenesis and counters resistance to BRAFV600E and MEK1\/2 inhibitors. Cancer Res 2017,77(22),6240-6252","journal-title":"Cancer Res"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"4271","DOI":"10.1158\/1078-0432.CCR-17-3705","volume":"24","author":"Xu M.","year":"2018","unstructured":"Xu M.; Casio M.; Range D.E.; Sosa J.A.; Counter C.M.; Copper chelation as targeted therapy in a mouse model of oncogenic BRAF-driven papillary thyroid cancer. Clin Cancer Res 2018,24(17),4271-4281","journal-title":"Clin Cancer Res"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.1039\/C5MT00149H","volume":"7","author":"Denoyer D.","year":"2015","unstructured":"Denoyer D.; Masaldan S.; La Fontaine S.; Cater M.A.; Targeting copper in cancer therapy: \u2018Copper that cancer\u2019. Metallomics 2015,7(11),1459-1476","journal-title":"Metallomics"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00204-015-1579-5","volume":"90","author":"Valko M.","year":"2016","unstructured":"Valko M.; Jomova K.; Rhodes C.J.; Ku\u010da K.; Mus\u00edlek K.; Redox- and non-redox-metal-induced formation of free radicals and their role in human disease. Arch Toxicol 2016,90(1),1-37","journal-title":"Arch Toxicol"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1016\/j.ccr.2010.04.011","volume":"17","author":"Ishida S.","year":"2010","unstructured":"Ishida S.; McCormick F.; Smith-McCune K.; Hanahan D.; Enhancing tumor-specific uptake of the anticancer drug cisplatin with a copper chelator. Cancer Cell 2010,17(6),574-583","journal-title":"Cancer Cell"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1021\/cr400135x","volume":"114","author":"Santini C.","year":"2014","unstructured":"Santini C.; Pellei M.; Gandin V.; Porchia M.; Tisato F.; Marzano C.; Advances in copper complexes as anticancer agents. Chem Rev 2014,114(1),815-862","journal-title":"Chem Rev"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1038\/nchem.2381","volume":"7","author":"Wang J.","year":"2015","unstructured":"Wang J.; Luo C.; Shan C.; You Q.; Lu J.; Elf S.; Zhou Y.; Wen Y.; Vinkenborg J.L.; Fan J.; Kang H.; Lin R.; Han D.; Xie Y.; Karpus J.; Chen S.; Ouyang S.; Luan C.; Zhang N.; Ding H.; Merkx M.; Liu H.; Chen J.; Jiang H.; He C.; Inhibition of human copper trafficking by a small molecule significantly attenuates cancer cell proliferation. Nat Chem 2015,7(12),968-979","journal-title":"Nat Chem"},{"key":"ref=23","doi-asserted-by":"crossref","first-page":"16973","DOI":"10.1039\/C8RA00954F","volume":"30","author":"Mahendiran D.","year":"2018","unstructured":"Mahendiran D.; Amuthakala S.; Bhuvanesh N.S.P.; Kumar R.S.; Rahiman A.K.; Copper complexes as prospective anticancer agents: In vitro and in vivo evaluation, selective targeting of cancer cells by DNA damage and S phase arrest. RSC Adv 2018,30,16973-16990","journal-title":"RSC Adv"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"1526","DOI":"10.2174\/1871520617666170327144122","volume":"17","author":"Abdel-Mohsen M.A.","year":"2017","unstructured":"Abdel-Mohsen M.A.; Abdel Malak C.A.; Abou Yossef M.A.; El-Shafey E.S.; Antitumor activity of copper (i)-nicotinate complex and autophagy modulation in hcc1806 breast cancer cells. Anticancer Agents Med Chem 2017,17(11),1526-1536","journal-title":"Anticancer Agents Med Chem"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"3989","DOI":"10.1080\/00958972.2013.858136","volume":"66","author":"Anbu S.","year":"2013","unstructured":"Anbu S.; Killivalavan A.; Alegria E.C.B.A.; Mathan G.; Kandaswamy M.; Effect of 1,10-phenanthroline on DNA binding, DNA cleavage, cytotoxic and lactate dehydrogenase inhibition properties of Robson type macrocyclic dicopper(II) complex. J Coord Chem 2013,66(22),3989-4003","journal-title":"J Coord Chem"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"10519","DOI":"10.1021\/ic201349s","volume":"50","author":"Bortolotto T.","year":"2011","unstructured":"Bortolotto T.; Silva P.P.; Neves A.; Pereira-Maia E.C.; Terenzi H.; Photoinduced DNA cleavage promoted by two copper(II) complexes of tetracyclines and 1,10-phenanthroline. Inorg Chem 2011,50(21),10519-10521","journal-title":"Inorg Chem"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"424","DOI":"10.2174\/1871520616666160513130204","volume":"17","author":"Cadavid-Vargas J.F.","year":"2017","unstructured":"Cadavid-Vargas J.F.; Leon I.E.; Etcheverry S.B.; Santi E.; Torre M.H.; Di Virgilio A.L.; Copper(II) complexes with saccharinate and glutamine as antitumor agents: Cytoand genotoxicity in human osteosarcoma cells. Anticancer Agents Med Chem 2017,17(3),424-433","journal-title":"Anticancer Agents Med Chem"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"5237","DOI":"10.1038\/s41598-019-41063-x","volume":"9","author":"Hussain A.","year":"2019","unstructured":"Hussain A.; AlAjmi M.F.; Rehman M.T.; Amir S.; Husain F.M.; Alsalme A.; Siddiqui M.A.; AlKhedhairy A.A.; Khan R.A.; Copper(II) complexes as potential anticancer and Nonsteroidal anti-inflammatory agents: In vitro and in vivo studies. Sci Rep 2019,9(1),5237","journal-title":"Sci Rep"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.2174\/1389557518666180423145825","volume":"18","author":"Katarzyna M.","year":"2018","unstructured":"Katarzyna M.; Anna S.; Zielinska-Blizniewska H.; Ireneusz M.; An evaluation of the antioxidant and anticancer properties of complex compounds of copper (ii), platinum (ii), palladium (ii) and ruthenium (iii) for use in cancer therapy. Mini Rev Med Chem 2018,18(16),1373-1381","journal-title":"Mini Rev Med Chem"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1016\/j.poly.2016.09.012","volume":"119","author":"Kostelidou A.","year":"2016","unstructured":"Kostelidou A.; Kalogiannis S.; Begou O-A.; Perdih F.; Turel I.; Psomas G.; Synthesis, structure and biological activity of copper(II) complexes with gatifloxacin. Polyhedron 2016,119,359-370","journal-title":"Polyhedron"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"5049","DOI":"10.1039\/C8DT00794B","volume":"47","author":"Shi X.","year":"2018","unstructured":"Shi X.; Chen Z.; Wang Y.; Guo Z.; Wang X.; Hypotoxic copper complexes with potent anti-metastatic and anti-angiogenic activities against cancer cells. Dalton Trans 2018,47(14),5049-5054","journal-title":"Dalton Trans"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1186\/1471-2407-14-527","volume":"14","author":"Fatfat M.","year":"2014","unstructured":"Fatfat M.; Merhi R.A.; Rahal O.; Stoyanovsky D.A.; Zaki A.; Haidar H.; Kagan V.E.; Gali-Muhtasib H.; Machaca K.; Copper chelation selectively kills colon cancer cells through redox cycling and generation of reactive oxygen species. BMC Cancer 2014,14(1),527","journal-title":"BMC Cancer"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1080\/00958972.2016.1260711","volume":"70","author":"Low M.L.","year":"2017","unstructured":"Low M.L.; Chan C.W.; Ng P.Y.; Ooi I.H.; Maah M.J.; Chye S.M.; Tan K.W.; Ng S.W.; Ng C.H.; Ternary and binary copper(II) complexes: Synthesis, characterization, ROS-inductive, proteasome inhibitory, and anticancer properties. J Coord Chem 2017,70(2),223-241","journal-title":"J Coord Chem"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"1603","DOI":"10.1016\/j.jinorgbio.2011.08.022","volume":"105","author":"Reddy P.R.","year":"2011","unstructured":"Reddy P.R.; Shilpa A.; Raju N.; Raghavaiah P.; Synthesis, structure, DNA binding and cleavage properties of ternary amino acid Schiff base-phen\/bipy Cu(II) complexes. J Inorg Biochem 2011,105(12),1603-1612","journal-title":"J Inorg Biochem"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"6414","DOI":"10.1021\/ic101791r","volume":"50","author":"Silva P.P.","year":"2011","unstructured":"Silva P.P.; Guerra W.; Silveira J.N.; Ferreira A.M.D.C.; Bortolotto T.; Fischer F.L.; Terenzi H.; Neves A.; Pereira-Maia E.C.; Two new ternary complexes of copper(II) with tetracycline or doxycycline and 1,10-phenanthroline and their potential as antitumoral: Cytotoxicity and DNA cleavage. Inorg Chem 2011,50(14),6414-6424","journal-title":"Inorg Chem"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1038\/s41418-017-0012-4","volume":"25","author":"Galluzzi L.","year":"2018","unstructured":"Galluzzi L.; Vitale I.; Aaronson S.A.; Abrams J.M.; Adam D.; Agostinis P.; Alnemri E.S.; Altucci L.; Amelio I.; Andrews D.W.; Annicchiarico-Petruzzelli M.; Antonov A.V.; Arama E.; Baehrecke E.H.; Barlev N.A.; Bazan N.G.; Bernassola F.; Bertrand M.J.M.; Bianchi K.; Blagosklonny M.V.; Blomgren K.; Borner C.; Boya P.; Brenner C.; Campanella M.; Candi E.; Carmona-Gutierrez D.; Cecconi F.; Chan F.K.M.; Chandel N.S.; Cheng E.H.; Chipuk J.E.; Cidlowski J.A.; Ciechanover A.; Cohen G.M.; Conrad M.; Cubillos-Ruiz J.R.; Czabotar P.E.; D\u2019Angiolella V.; Dawson T.M.; Dawson V.L.; De Laurenzi V.; De Maria R.; Debatin K.M.; DeBerardinis R.J.; Deshmukh M.; Di Daniele N.; Di Virgilio F.; Dixit V.M.; Dixon S.J.; Duckett C.S.; Dynlacht B.D.; El-Deiry W.S.; Elrod J.W.; Fimia G.M.; Fulda S.; Garc\u00eda-S\u00e1ez A.J.; Garg A.D.; Garrido C.; Gavathiotis E.; Golstein P.; Gottlieb E.; Green D.R.; Greene L.A.; Gronemeyer H.; Gross A.; Hajnoczky G.; Hardwick J.M.; Harris I.S.; Hengartner M.O.; Hetz C.; Ichijo H.; J\u00e4\u00e4ttel\u00e4 M.; Joseph B.; Jost P.J.; Juin P.P.; Kaiser W.J.; Karin M.; Kaufmann T.; Kepp O.; Kimchi A.; Kitsis R.N.; Klionsky D.J.; Knight R.A.; Kumar S.; Lee S.W.; Lemasters J.J.; Levine B.; Linkermann A.; Lipton S.A.; Lockshin R.A.; L\u00f3pez-Ot\u00edn C.; Lowe S.W.; Luedde T.; Lugli E.; MacFarlane M.; Madeo F.; Malewicz M.; Malorni W.; Manic G.; Marine J.C.; Martin S.J.; Martinou J.C.; Medema J.P.; Mehlen P.; Meier P.; Melino S.; Miao E.A.; Molkentin J.D.; Moll U.M.; Mu\u00f1oz-Pinedo C.; Nagata S.; Nu\u00f1ez G.; Oberst A.; Oren M.; Overholtzer M.; Pagano M.; Panaretakis T.; Pasparakis M.; Penninger J.M.; Pereira D.M.; Pervaiz S.; Peter M.E.; Piacentini M.; Pinton P.; Prehn J.H.M.; Puthalakath H.; Rabinovich G.A.; Rehm M.; Rizzuto R.; Rodrigues C.M.P.; Rubinsztein D.C.; Rudel T.; Ryan K.M.; Sayan E.; Scorrano L.; Shao F.; Shi Y.; Silke J.; Simon H.U.; Sistigu A.; Stockwell B.R.; Strasser A.; Szabadkai G.; Tait S.W.G.; Tang D.; Tavernarakis N.; Thorburn A.; Tsujimoto Y.; Turk B.; Vanden Berghe T.; Vandenabeele P.; Vander Heiden M.G.; Villunger A.; Virgin H.W.; Vousden K.H.; Vucic D.; Wagner E.F.; Walczak H.; Wallach D.; Wang Y.; Wells J.A.; Wood W.; Yuan J.; Zakeri Z.; Zhivotovsky B.; Zitvogel L.; Melino G.; Kroemer G.; Molecular mechanisms of cell death: Recommendations of the nomenclature committee on cell death 2018. Cell Death Differ 2018,25(3),486-541","journal-title":"Cell Death Differ"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"622","DOI":"10.3892\/ijo.2013.1973","volume":"43","author":"Kim I.W.","year":"2013","unstructured":"Kim I.W.; Lee J.H.; Kwon Y.N.; Yun E.Y.; Nam S.H.; Ahn M.Y.; Kang D.C.; Hwang J.S.; Anticancer activity of a synthetic peptide derived from harmoniasin, an antibacterial peptide from the ladybug Harmonia axyridis. Int J Oncol 2013,43(2),622-628","journal-title":"Int J Oncol"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1007\/978-1-62703-290-2_7","volume":"979","author":"Chan F.K.M.","year":"2013","unstructured":"Chan F.K.M.; Moriwaki K.; De Rosa M.J.; Detection of necrosis by release of lactate dehydrogenase activity. Methods Mol Biol 2013,979,65-70","journal-title":"Methods Mol Biol"},{"key":"ref=39","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioorg.2019.102967","volume":"88","author":"Gholampour M.","year":"2019","unstructured":"Gholampour M.; Ranjbar S.; Edraki N.; Mohabbati M.; Firuzi O.; Khoshneviszadeh M.; Click chemistry-assisted synthesis of novel aminonaphthoquinone-1,2,3-triazole hybrids and investigation of their cytotoxicity and cancer cell cycle alterations. Bioorg Chem 2019,88","journal-title":"Bioorg Chem"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"101","DOI":"10.2174\/1871520619666181224121004","volume":"19","author":"Gezici S.","year":"2019","unstructured":"Gezici S.; \u015eekero\u011flu N.; Current perspectives in the application of medicinal plants against cancer: Novel therapeutic agents. Anticancer Agents Med Chem 2019,19(1),101-111","journal-title":"Anticancer Agents Med Chem"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"147","DOI":"10.2174\/18715206113139990313","volume":"14","author":"Wang K.","year":"2014","unstructured":"Wang K.; Gao E.; Recent advances in multinuclear complexes as potential anticancer and DNA binding agents. Anticancer Agents Med Chem 2014,14(1),147-169","journal-title":"Anticancer Agents Med Chem"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"19449","DOI":"10.1038\/srep19449","volume":"6","author":"Zeng L.","year":"2016","unstructured":"Zeng L.; Chen Y.; Liu J.; Huang H.; Guan R.; Ji L.; Chao H.; Ruthenium(ii) complexes with 2-phenylimidazo[4,5-f][1,10]phenanthroline derivatives that strongly combat cisplatin-resistant tumor cells. Sci Rep 2016,6(1),19449","journal-title":"Sci Rep"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1007\/s10534-018-0096-4","volume":"31","author":"Foo J.B.","year":"2018","unstructured":"Foo J.B.; Low M.L.; Lim J.H.; Lor Y.Z.; Zainol Abidin R.; Eh Dam V.; Abdul Rahman N.; Beh C.Y.; Chan L.C.; How C.W.; Tor Y.S.; Saiful Yazan L.; Copper complex derived from S-benzyldithiocarbazate and 3-acetylcoumarin induced apoptosis in breast cancer cell. Biometals 2018,31(4),505-515","journal-title":"Biometals"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1007\/s10534-014-9710-2","volume":"27","author":"Wu J.","year":"2014","unstructured":"Wu J.; Chen W.; Yin Y.; Zheng Z.; Zou G.; Probing the cell death signaling pathway of HepG2 cell line induced by copper-1,10-phenanthroline complex. Biometals 2014,27(3),445-458","journal-title":"Biometals"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1016\/S0026-0495(03)00094-5","volume":"52","author":"Hamel F.G.","year":"2003","unstructured":"Hamel F.G.; Upward J.L.; Siford G.L.; Duckworth W.C.; Inhibition of proteasome activity by selected amino acids. Metabolism 2003,52(7),810-814","journal-title":"Metabolism"},{"key":"ref=46","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0148775","volume":"11","author":"Phang C.W.","year":"2016","unstructured":"Phang C.W.; Karsani S.A.; Sethi G.; Abd Malek S.N.; Flavokawain C.; Flavokawain c inhibits cell cycle and promotes apoptosis, associated with endoplasmic reticulum stress and regulation of mapks and akt signaling pathways in hct 116 human colon carcinoma cells. PLoS One 2016,11(2)","journal-title":"PLoS One"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"3944","DOI":"10.1158\/1078-0432.CCR-10-0964","volume":"16","author":"Pisano C.","year":"2010","unstructured":"Pisano C.; Vesci L.; Milazzo F.M.; Guglielmi M.B.; Foder\u00e0 R.; Barbarino M.; D\u2019Incalci M.; Zucchetti M.; Petrangolini G.; Tortoreto M.; Perego P.; Zuco V.; Orlandi A.; Passeri D.; Carminati P.; Cavazza C.; Zunino F.; Metabolic approach to the enhancement of antitumor effect of chemotherapy: A key role of acetyl-L-carnitine. Clin Cancer Res 2010,16(15),3944-3953","journal-title":"Clin Cancer Res"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1016\/j.ejmech.2017.08.062","volume":"139","author":"Yilmaz V.T.","year":"2017","unstructured":"Yilmaz V.T.; Icsel C.; Batur J.; Aydinlik S.; Sahinturk P.; Aygun M.; Structures and biochemical evaluation of silver(I) 5,5-diethylbarbiturate complexes with bis(diphenylphosphino)alkanes as potential antimicrobial and anticancer agents. Eur J Med Chem 2017,139,901-916","journal-title":"Eur J Med Chem"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1007\/978-1-61779-108-6_6","volume":"740","author":"Ke N.","year":"2011","unstructured":"Ke N.; Wang X.; Xu X.; Abassi Y.A.; The xCELLigence system for real-time and label-free monitoring of cell viability. Methods Mol Biol 2011,740,33-43","journal-title":"Methods Mol Biol"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1038\/nrc.2016.138","volume":"17","author":"Otto T.","year":"2017","unstructured":"Otto T.; Sicinski P.; Cell cycle proteins as promising targets in cancer therapy. Nat Rev Cancer 2017,17(2),93-115","journal-title":"Nat Rev Cancer"},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"687","DOI":"10.2174\/1871520620666200213102849","volume":"20","author":"Jin G.","year":"2020","unstructured":"Jin G.; Wang K.; Liu Y.; Liu X.; Zhang X.; Zhang H.; Proteomic level changes on treatment in mcf-7\/ddp breast cancer drug- resistant cells. Anticancer Agents Med Chem 2020,20(6),687-699","journal-title":"Anticancer Agents Med Chem"},{"key":"ref=52","doi-asserted-by":"publisher","first-page":"330","DOI":"10.3389\/fphar.2019.00330","volume":"10","author":"Doan P.","year":"2019","unstructured":"Doan P.; Musa A.; Candeias N.R.; Emmert-Streib F.; Yli-Harja O.; Kandhavelu M.; Alkylaminophenol induces g1\/s phase cell cycle arrest in glioblastoma cells through p53 and cyclin-dependent kinase signaling pathway. Front Pharmacol 2019,10(330),330","journal-title":"Front Pharmacol"},{"key":"ref=53","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/540463","volume":"2014","author":"Hajrezaie M.","year":"2014","unstructured":"Hajrezaie M.; Paydar M.; Moghadamtousi S.Z.; Hassandarvish P.; Gwaram N.S.; Zahedifard M.; Rouhollahi E.; Karimian H.; Looi C.Y.; Ali H.M.; Abdul Majid N.; Abdulla M.A.; A Schiff base-derived copper (II) complex is a potent inducer of apoptosis in colon cancer cells by activating the intrinsic pathway. ScientificWorldJournal 2014,2014","journal-title":"ScientificWorldJournal"},{"key":"ref=54","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.poly.2017.04.018","volume":"132","author":"Hu J.","year":"2017","unstructured":"Hu J.; Liao C.; Guo Y.; Yang F.; Sang W.; Zhao J.a.; Copper(II) complexes inducing apoptosis in cancer cells, and demonstrating DNA and HSA interactions. Polyhedron 2017,132,28-38","journal-title":"Polyhedron"},{"key":"ref=55","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1038\/nrm3722","volume":"15","author":"Czabotar P.E.","year":"2014","unstructured":"Czabotar P.E.; Lessene G.; Strasser A.; Adams J.M.; Control of apoptosis by the BCL-2 protein family: Implications for physiology and therapy. Nat Rev Mol Cell Biol 2014,15(1),49-63","journal-title":"Nat Rev Mol Cell Biol"},{"key":"ref=56","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1038\/s41580-019-0173-8","volume":"21","author":"Bock F.J.","year":"2020","unstructured":"Bock F.J.; Tait S.W.G.; Mitochondria as multifaceted regulators of cell death. Nat Rev Mol Cell Biol 2020,21(2),85-100","journal-title":"Nat Rev Mol Cell Biol"},{"key":"ref=57","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1038\/nrc.2016.58","volume":"16","author":"Ichim G.","year":"2016","unstructured":"Ichim G.; Tait S.W.G.; A fate worse than death: Apoptosis as an oncogenic process. Nat Rev Cancer 2016,16(8),539-548","journal-title":"Nat Rev Cancer"},{"key":"ref=58","doi-asserted-by":"publisher","first-page":"5045","DOI":"10.1038\/s41598-020-61876-5","volume":"10","author":"Cheng M.H.","year":"2020","unstructured":"Cheng M.H.; Pan C.Y.; Chen N.F.; Yang S.N.; Hsieh S.; Wen Z.H.; Chen W.F.; Wang J.W.; Lu W.H.; Kuo H.M.; Piscidin-1 induces apoptosis via mitochondrial reactive oxygen species-regulated mitochondrial dysfunction in human osteosarcoma cells. Sci Rep 2020,10(1),5045","journal-title":"Sci Rep"},{"key":"ref=59","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1016\/j.freeradbiomed.2009.12.022","volume":"48","author":"Circu M.L.","year":"2010","unstructured":"Circu M.L.; Aw T.Y.; Reactive oxygen species, cellular redox systems, and apoptosis. Free Radic Biol Med 2010,48(6),749-762","journal-title":"Free Radic Biol Med"},{"key":"ref=60","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1038\/sj.cdd.4401271","volume":"10","author":"McDonnell M.A.","year":"2003","unstructured":"McDonnell M.A.; Wang D.; Khan S.M.; Vander Heiden M.G.; Kelekar A.; Caspase-9 is activated in a cytochrome c-independent manner early during TNFalpha-induced apoptosis in murine cells. Cell Death Differ 2003,10(9),1005-1015","journal-title":"Cell Death Differ"},{"key":"ref=61","doi-asserted-by":"publisher","first-page":"34287","DOI":"10.1074\/jbc.M204973200","volume":"277","author":"Morishima N.","year":"2002","unstructured":"Morishima N.; Nakanishi K.; Takenouchi H.; Shibata T.; Yasuhiko Y.; An endoplasmic reticulum stress-specific caspase cascade in apoptosis. Cytochrome c-independent activation of caspase-9 by caspase-12. J Biol Chem 2002,277(37),34287-34294","journal-title":"J Biol Chem"},{"key":"ref=62","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1007\/s10495-016-1217-6","volume":"21","author":"Zhang Q.","year":"2016","unstructured":"Zhang Q.; Liu J.; Chen S.; Liu J.; Liu L.; Liu G.; Wang F.; Jiang W.; Zhang C.; Wang S.; Yuan X.; Caspase-12 is involved in stretch-induced apoptosis mediated endoplasmic reticulum stress. Apoptosis 2016,21(4),432-442","journal-title":"Apoptosis"},{"key":"ref=63","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1038\/nrm3737","volume":"15","author":"Vanden Berghe T.","year":"2014","unstructured":"Vanden Berghe T.; Linkermann A.; Jouan-Lanhouet S.; Walczak H.; Vandenabeele P.; Regulated necrosis: The expanding network of non-apoptotic cell death pathways. Nat Rev Mol Cell Biol 2014,15(2),135-147","journal-title":"Nat Rev Mol Cell Biol"},{"key":"ref=64","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41392-017-0001-6","volume":"3","author":"Chen Q.","year":"2018","unstructured":"Chen Q.; Kang J.; Fu C.; The independence of and associations among apoptosis, autophagy, and necrosis. Signal transduction and targeted therapy 2018,3,1-11","journal-title":"Signal transduction and targeted therapy"},{"key":"ref=65","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1038\/nature12634","volume":"502","author":"Kandoth C.","year":"2013","unstructured":"Kandoth C.; McLellan M.D.; Vandin F.; Ye K.; Niu B.; Lu C.; Xie M.; Zhang Q.; McMichael J.F.; Wyczalkowski M.A.; Leiserson M.D.M.; Miller C.A.; Welch J.S.; Walter M.J.; Wendl M.C.; Ley T.J.; Wilson R.K.; Raphael B.J.; Ding L.; Mutational landscape and significance across 12 major cancer types. Nature 2013,502(7471),333-339","journal-title":"Nature"},{"key":"ref=66","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1038\/nmeth.4364","volume":"14","author":"Porta-Pardo E.","year":"2017","unstructured":"Porta-Pardo E.; Kamburov A.; Tamborero D.; Pons T.; Grases D.; Valencia A.; Lopez-Bigas N.; Getz G.; Godzik A.; Comparison of algorithms for the detection of cancer drivers at subgene resolution. Nat Methods 2017,14(8),782-788","journal-title":"Nat Methods"},{"key":"ref=67","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1038\/cdd.2017.169","volume":"25","author":"Aubrey B.J.","year":"2018","unstructured":"Aubrey B.J.; Kelly G.L.; Janic A.; Herold M.J.; Strasser A.; How does p53 induce apoptosis and how does this relate to p53-mediated tumour suppression? Cell Death Differ 2018,25(1),104-113","journal-title":"Cell Death Differ"},{"key":"ref=68","doi-asserted-by":"publisher","first-page":"1252","DOI":"10.1038\/onc.2012.148","volume":"32","author":"Muller P.A.J.","year":"2013","unstructured":"Muller P.A.J.; Trinidad A.G.; Timpson P.; Morton J.P.; Zanivan S.; van den Berghe P.V.E.; Nixon C.; Karim S.A.; Caswell P.T.; Noll J.E.; Coffill C.R.; Lane D.P.; Sansom O.J.; Neilsen P.M.; Norman J.C.; Vousden K.H.; Mutant p53 enhances MET trafficking and signalling to drive cell scattering and invasion. Oncogene 2013,32(10),1252-1265","journal-title":"Oncogene"},{"key":"ref=69","doi-asserted-by":"publisher","first-page":"E8433","DOI":"10.1073\/pnas.1612711114","volume":"113","author":"Vogiatzi F.","year":"2016","unstructured":"Vogiatzi F.; Brandt D.T.; Schneikert J.; Fuchs J.; Grikscheit K.; Wanzel M.; Pavlakis E.; Charles J.P.; Timofeev O.; Nist A.; Mernberger M.; Kantelhardt E.J.; Siebolts U.; Bartel F.; Jacob R.; Rath A.; Moll R.; Grosse R.; Stiewe T.; Mutant p53 promotes tumor progression and metastasis by the endoplasmic reticulum UDPase ENTPD5. Proc Natl Acad Sci USA 2016,113(52),E8433-E8442","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=70","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.bbamcr.2014.10.003","volume":"1853","author":"Fiorini C.","year":"2015","unstructured":"Fiorini C.; Cordani M.; Padroni C.; Blandino G.; Di Agostino S.; Donadelli M.; Mutant p53 stimulates chemoresistance of pancreatic adenocarcinoma cells to gemcitabine. Biochim Biophys Acta 2015,1853(1),89-100","journal-title":"Biochim Biophys Acta"},{"key":"ref=71","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1038\/s41418-018-0246-9","volume":"26","author":"Mantovani F.","year":"2019","unstructured":"Mantovani F.; Collavin L.; Del Sal G.; Mutant p53 as a guardian of the cancer cell. Cell Death Differ 2019,26(2),199-212","journal-title":"Cell Death Differ"},{"key":"ref=72","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1016\/j.canlet.2014.12.003","volume":"357","author":"Yang L.","year":"2015","unstructured":"Yang L.; Zhou Y.; Li Y.; Zhou J.; Wu Y.; Cui Y.; Yang G.; Hong Y.; Mutations of p53 and KRAS activate NF-\u03baB to promote chemoresistance and tumorigenesis via dysregulation of cell cycle and suppression of apoptosis in lung cancer cells. Cancer Lett 2015,357(2),520-526","journal-title":"Cancer Lett"},{"key":"ref=73","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a026104","volume":"6","author":"Chen J.","year":"2016","unstructured":"Chen J.; The cell-cycle arrest and apoptotic functions of p53 in tumor initiation and progression. Cold Spring Harb Perspect Med 2016,6(3)","journal-title":"Cold Spring Harb Perspect Med"},{"key":"ref=74","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/1477-7819-11-22","volume":"11","author":"Zhu H-B.","year":"2013","unstructured":"Zhu H-B.; Yang K.; Xie Y-Q.; Lin Y-W.; Mao Q-Q.; Xie L-P.; Silencing of mutant p53 by siRNA induces cell cycle arrest and apoptosis in human bladder cancer cells. World J Surg Oncol 2013,11(1),22","journal-title":"World J Surg Oncol"},{"key":"ref=75","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/s13046-018-0705-7","volume":"37","year":"2018","unstructured":"Blandino, G.; Di Agostino, S. New therapeutic strategies to treat human cancers expressing mutant p53 proteins. J Exp Clin Cancer Res, 2018,37(1),30","journal-title":"J Exp Clin Cancer Res,"}],"container-title":["Anti-Cancer Agents in Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1871520621666210708100019","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/194604\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1871520621666210708100019","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,4]],"date-time":"2023-08-04T13:53:03Z","timestamp":1691157183000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/194604\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3]]},"references-count":75,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,3]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1871520621666210708100019","relation":{},"ISSN":["1871-5206"],"issn-type":[{"type":"print","value":"1871-5206"}],"subject":[],"published":{"date-parts":[[2022,3]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2020-12-25","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-03-26","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-04-26","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-02-18","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}